El ictus en pacientes muy ancianos: mitos y realidades

Serrano‐Villar, Sergio; Fresco, Gema; Ruiz-Artacho, Pedro; Bravo, Ana Julia; Valencia, Cristina Gutiérrez; Fuentes‐Ferrer, Manuel; Estrada, Vicente; Porta‐Etessam, Jesús

doi:10.1016/j.medcli.2012.05.036

Cited by 21 publications

(5 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of hypercholesterolemia in patients with IS ranged from 40% to 70% [ 39 – 41 , 47 – 60 ]. The proportion of treated patients was lower than that found in ACS or CHD patients.…”

Section: Resultsmentioning

confidence: 99%

“…It has been shown that hypercholesterolemia is significantly present among patients with an increased vascular risk and those who have already suffered a CV event: 50–84% of patients with DM [ 44 , 57 , 67 , 68 , 74 ], 30–50% of high risk patient [ 1 , 3 , 76 – 78 ], and between 35% and above 80% in those with overt CVD, depending on the type of event [ 15 – 41 , 44 – 60 ]. The association of this condition with the risk of CV events [ 9 , 83 ] makes it all the more necessary to endorse the interventions aimed at managing the modifiable risk factors (diet and exercise), to prescribe a LLT accordingly to individual’s CV risk [ 7 ], and also to plan an adequate monitoring of the pharmacological therapies implemented to maximize their benefit.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain

et al. 2015

View full text Add to dashboard Cite

IntroductionCardiovascular diseases (CVDs) represent a major Public Health burden. High serum cholesterol levels have been linked to major CV risk. The objectives of this study were to review the epidemiology of hypercholesterolemia in high risk CV patients from Spain, by assessing its prevalence, the proportion of diagnosed patients undergoing pharmacological treatment and the degree of attained lipid control.MethodsA systematic literature review was carried out using Medline and two Spanish databases. Manuscripts containing information on hypercholesterolemia in several high CV risk groups [diabetes mellitus (DM), Systematic COronary Risk Evaluation (SCORE) risk >5, or documented CVD], published between January 2010 and October 2014, were included.ResultsOf the 1947 published references initially retrieved, a full-text review was done on 264 manuscripts and 120 were finally included. Prevalence of hypercholesterolemia ranged from 50 to 84% in diabetics, 30–60% in patients with DM or elevated SCORE risk, 64–74% with coronary heart disease, 40–70% in stroke patients, and 60–80% in those with peripheral artery disease. Despite the finding that most of them were on pharmacological treatment, acceptable control of serum lipids was very variable, ranging from 15% to 65%. Among those with heterozygous familial hypercholesterolemia, 95–100% received treatment but less than 50% achieved their therapeutic goals.ConclusionsAn elevated prevalence of hypercholesterolemia can be found in targeted groups at high CV risk. Although most patients are receiving pharmacological treatment, rates of lipid control continue to be low, both in primary and secondary prevention.Electronic supplementary materialThe online version of this article (doi:10.1007/s12325-015-0252-y) contains supplementary material, which is available to authorized users.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Consequently, survivors need and use numerous health resources, including intensive care, rehabilitation, social and community services [13,14]. With the progressive aging of the population, the magnitude of the problem and its consequences are increasing [15,16]. Implementation of regional and national stroke care and quality systems and improvement initiatives have a significant impact on reducing stroke-related morbidity and mortality and improving outcomes [5,17].…”

Section: Discussionmentioning

confidence: 99%

Autonomy Outcomes Measured with Barthel Index in Patients with Ischaemic Stroke during SARS-CoV-2 Pandemic. A Descriptive Study

Pego Pérez

2022

OAJNN

View full text Add to dashboard Cite

Background: Acute stroke is the 3rd cause of mortality, the 1st in disability in the adult population, studies focused on the subacute stroke phase are less frequent, and those that focus on longer-term evolution are rare. Aim: To determine the functional repercussion in patients with ischemic stroke during the SARS-CoV-2 pandemic. Methods: A qualitative and retrospective study with a sample of 674 patients with acute ischaemic stroke that were selected. The outcomes were measured with Barthel index. Results: The distribution in the moderate and severe degrees has been higher for the year 2020, in the independent and mild degrees it has been higher in the years 2019 and 2021, for the degree of total dependence it has been higher in the years 2019 and 2021. No significant correlation was found between age and the result of the Barthel scale or between the year in which the stroke occurred and the result of the Barthel scale. Conclusion: No relationship is seen between the SARS-CoV-2 pandemic and worsening of functionality. The structural changes during the pandemic and the reduction in personnel have not affected the diagnosis and involvement of ischemic stroke. The effort of the staff, to maintain adequate care, has been decisive in the functional results of the patients.

show abstract

“…Nos llama la atenció n que afirmen que ningú n paciente mayor de 85 añ os recibió trombó lisis intravenosa, obviando los 15 pacientes de este grupo etario que recibieron tratamiento fibrinolítico en ese período, datos que obran en el registro europeo de trombó lisis (SITS) 2 y para cuya utilizació n contamos con el correspondiente consentimiento informado y aprobació n del Comité É tico de Investigació n, y como muy bien citan los autores del trabajo, nos valió la participació n en el estudio internacional de trombó lisis en el anciano 3 .…”

Section: Stroke In Very Old Patients and Ethics In Clinical Researchunclassified

El ictus en pacientes muy ancianos y deontología en la investigación clínica

Egido

Garcia

2015

Medicina Clínica

View full text Add to dashboard Cite

El ictus en pacientes muy ancianos: mitos y realidades

Cited by 21 publications

References 31 publications

Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain

Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain

Autonomy Outcomes Measured with Barthel Index in Patients with Ischaemic Stroke during SARS-CoV-2 Pandemic. A Descriptive Study

El ictus en pacientes muy ancianos y deontología en la investigación clínica

Contact Info

Product

Resources

About